RecallDepth
Class II Ongoing

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

This recall is currently active, issued November 20, 2024. It was issued by Cipla Usa, Inc..

Company
Cipla Usa, Inc.
Recall Initiated
October 23, 2024
Posted
November 20, 2024
Recall Number
D-0043-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,875 boxes (cipla and exlan)
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Distribution

USA nationwide.

Lot / Code Info

Lot # NB240316, Exp 12/31/25

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls